116 related articles for article (PubMed ID: 2691221)
1. On the relative importance of D-1 vs. D-2 dopaminergic receptors in the control of audiogenic seizures in ethanol withdrawn rats.
Trzaskowska E; Krzaścik P; Staniszewska A; Puciłowski O; Kostowski W
Drug Alcohol Depend; 1989 Dec; 24(3):265-7. PubMed ID: 2691221
[TBL] [Abstract][Full Text] [Related]
2. Effects of 6-hydroxydopamine-induced lesions of A10 dopaminergic neurons and neuroleptic or bromocriptine treatment on ethanol withdrawal syndrome in rats.
Trzaskowska E; Puciłowski O; Kostowski W; Bidziński A
Pol J Pharmacol Pharm; 1983; 35(5):339-49. PubMed ID: 6141554
[TBL] [Abstract][Full Text] [Related]
3. Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion.
Rouillard C; Bédard P; Falardeau P; Di Paolo T
Eur J Pharmacol; 1988 Nov; 157(2-3):125-33. PubMed ID: 2975996
[TBL] [Abstract][Full Text] [Related]
4. Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors.
Morelli M; Fenu S; Di Chiara G
Life Sci; 1987 Jan; 40(3):245-51. PubMed ID: 2948094
[TBL] [Abstract][Full Text] [Related]
5. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
Monti JM; Fernández M; Jantos H
Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
[TBL] [Abstract][Full Text] [Related]
6. Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes.
Crowley WR; Parker SL; Armstrong WE; Wang W; Grosvenor CE
Neuroendocrinology; 1991 May; 53(5):493-502. PubMed ID: 1831247
[TBL] [Abstract][Full Text] [Related]
7. D-1 dopamine agonist administration reduces the threshold for convulsions produced by pilocarpine.
Barone P; Palma V; Parashos SA; Marin C; Chase TN; Campanella G
Boll Soc Ital Biol Sper; 1989 Apr; 65(4):337-41. PubMed ID: 2570598
[TBL] [Abstract][Full Text] [Related]
8. Effects of bromocriptine and haloperidol on ethanol withdrawal syndrome in rats.
Uzbay IT; Akarsu ES; Kayaalp SO
Pharmacol Biochem Behav; 1994 Dec; 49(4):969-74. PubMed ID: 7886115
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
Robertson GS; Robertson HA
Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
[TBL] [Abstract][Full Text] [Related]
10. Audiogenic seizures during ethanol withdrawal can be blocked by a delta opioid agonist.
Kotlińska J; Langwiński R
Drug Alcohol Depend; 1986 Dec; 18(4):361-7. PubMed ID: 3028746
[TBL] [Abstract][Full Text] [Related]
11. D-1 dopamine receptor stimulation potentiates neurophysiological effects of bromocriptine in rats with lesions of the nigrostriatal dopamine pathway.
Weick BG; Walters JR
Neuropharmacology; 1987 Jun; 26(6):641-4. PubMed ID: 2955245
[TBL] [Abstract][Full Text] [Related]
12. SKF 38393 potentiates yawning induced by LY 171555: further evidence against the autoreceptor hypothesis of yawning.
Spina L; Longoni R; Mulas A; Di Chiara G
Psychopharmacology (Berl); 1989; 98(4):567-8. PubMed ID: 2570436
[TBL] [Abstract][Full Text] [Related]
13. Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence for D1 receptor involvement.
Calabresi P; Mercuri N; Stanzione P; Stefani A; Bernardi G
Neuroscience; 1987 Mar; 20(3):757-71. PubMed ID: 2955246
[TBL] [Abstract][Full Text] [Related]
14. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamic D2 receptors mediate the preferential release of somatostatin-28 in response to dopaminergic stimulation.
Lewis BM; Dieguez C; Lewis M; Hall R; Scanlon MF
Endocrinology; 1986 Oct; 119(4):1712-7. PubMed ID: 2428601
[TBL] [Abstract][Full Text] [Related]
16. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of dopamine D-2 but not D-1 receptors reduces immobility time of rats in the forced swimming test: implication for antidepressant activity.
Borsini F; Lecci A; Mancinelli A; D'Aranno V; Meli A
Eur J Pharmacol; 1988 Apr; 148(3):301-7. PubMed ID: 2968270
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D1 receptor modulation of pilocarpine-induced convulsions.
Barone P; Parashos SA; Palma V; Marin C; Campanella G; Chase TN
Neuroscience; 1990; 34(1):209-17. PubMed ID: 2139189
[TBL] [Abstract][Full Text] [Related]
19. Selective blockade of dopamine D-1 receptor by SCH 23390 affects dopamine agonist binding to 3H-spiperone labeled D-2 receptors in rat striatum.
Zhang X; Segawa T
Jpn J Pharmacol; 1989 Jul; 50(3):333-45. PubMed ID: 2569545
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
Cunningham KA; Callahan PM; Appel JB
Eur J Pharmacol; 1985 Dec; 119(1-2):121-5. PubMed ID: 2935415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
